Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer - Di Cosimo S; Pérez-García JM; Bellet M; Dalenc F; Gil Gil MJ; Ruiz-Borrego M; Gavilá J; Aguirre E; Schmid P; Marmé F; Gligorov J; Schneeweiss A; et al. (2024)